Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.
J L Masferrer, … , K Seibert, P Needleman
J L Masferrer, … , K Seibert, P Needleman
Published October 1, 1990
Citation Information: J Clin Invest. 1990;86(4):1375-1379. https://doi.org/10.1172/JCI114850.
View: Text | PDF
Research Article Article has an altmetric score of 3

Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.

  • Text
  • PDF
Abstract

We have studied the effect of glucocorticoids administered in vivo on the activity and synthesis of the cyclooxygenase enzyme (COX) in mice treated with or without concurrent intravenous administration of LPS. Mouse peritoneal macrophages from LPS-treated animals showed a two to three fold increase in COX activity determined by the production of PGE2 and PGI2 after stimulation of the cells with exogenous arachidonate. Dexamethasone injected simultaneously with LPS, 12 h before killing of the animal and removal of the macrophages, completely blocked the LPS-induced increase COX activity in peritoneal macrophages. The regulation observed in COX activity by LPS and dexamethasone are due primarily to changes in COX mass as determined by immunoprecipitation of [35S]methionine endogenously labeled enzyme. In contrast, the COX present in the nonadherent cells and in renal medullary microsomes obtained from the same animals, showed no significant changes between treatments. These results indicate that LPS in vivo stimulates COX synthesis in the peritoneal macrophages but not in the kidney. The effect of dexamethasone to inhibit COX synthesis is selective to the LPS-induced enzyme.

Authors

J L Masferrer, B S Zweifel, K Seibert, P Needleman

×

Total citations by year

Year: 2025 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1985 1984 1981 1976 Total
Citations: 1 1 1 2 2 2 2 5 1 4 4 3 4 4 3 5 6 8 9 8 8 10 9 13 21 22 19 20 20 16 17 10 19 5 1 1 2 2 290
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (290)

Title and authors Publication Year
Exploring the potential link between human papillomavirus infection and coronary artery disease: a review of shared pathways and mechanisms.
Saha D, Dutta P, Rebello KR, Shankar A, Chakraborty A
Molecular and cellular biochemistry 2025
Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review.
Sohail R, Mathew M, Patel KK, Reddy SA, Haider Z, Naria M, Habib A, Abdin ZU, Razzaq Chaudhry W, Akbar A
Cureus 2023
Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2.
Granath C, Freiholtz D, Bredin F, Olsson C, Franco-Cereceda A, Björck HM
Journal of the American Heart Association 2022
Biochemistry of Drug Resistance
S Ahmed, SC Ojha, M Najam-ul-Haq, M Younus, MZ Hashmi
2021
Co-delivery of Dexamethasone and a MicroRNA-155 Inhibitor Using Dendrimer-Entrapped Gold Nanoparticles for Acute Lung Injury Therapy
C Li, J Li, Y Fan, D Wang, M Zhan, M Shen, X Shi
Biomacromolecules 2021
Control of immunity by glucocorticoids in health and disease
A Shimba, K Ikuta
Seminars in Immunopathology 2020
Application of per-residue energy decomposition to identify the set of amino acids critical for in silico prediction of COX-2 inhibitory activity
N Chaudhary, P Aparoy
Heliyon 2020
Murrayanine Attenuates Lipopolysaccharide-induced Inflammation and Protects Mice from Sepsis-associated Organ Failure
S Gupta, V Khajuria, A wani, Y Nalli, A Bhagat, A Ali, Z Ahmed
Basic & Clinical Pharmacology & Toxicology 2019
Nijkamp and Parnham's Principles of Immunopharmacology
MJ Parnham, FP Nijkamp, AG Rossi
2019
Molecular docking, molecular modeling, and molecular dynamics studies of azaisoflavone as dual COX-2 inhibitors and TP receptor antagonists
M Hadianawala, AD Mahapatra, JK Yadav, B Datta
Journal of Molecular Modeling 2018
Preparation and functionalization of acetylsalicylic acid loaded chitosan/gelatin membranes from ethanol-based suspensions via electrophoretic deposition
F Wang, P Huang, D Huang, Y Hu, K Ma, X Cai, T Jiang
Journal of Materials Chemistry B 2018
Kelley and Firestein's Textbook of Rheumatology
PE di Cesare, DR Haudenschild, J Samuels, SB Abramson
Kelley and Firestein's Textbook of Rheumatology 2017
Bergapten prevents lipopolysaccharide-induced inflammation in RAW264.7 cells through suppressing JAK/STAT activation and ROS production and increases the survival rate of mice after LPS challenge
Y Zhou, J Wang, W Yang, X Qi, L Lan, L Luo, Z Yin
International Immunopharmacology 2017
Involvement of Arachidonic Acid Metabolites Pathway and Nicotinic Acetylcholine Receptors (nAChRs) on Nicotine-induced Contractions (or Relaxations) in the Basilar Artery
Y Li, D Luo, X Chen, J Li, L Yan, T Li, Y Zhao, H Liu, X Ji, X Ma
International Journal of Pharmacology 2017
The amino analogue of β-boswellic acid efficiently attenuates the release of pro-inflammatory mediators than its parent compound through the suppression of NF-κB/IκBα signalling axis
S Gupta, AU Ahsan, A Wani, V Khajuria, LA Nazir, S Sharma, A Bhagat, PR Sharma, S Bhardwaj, KJ Peerzada, BA Shah, Z Ahmed
Cytokine 2017
Attenuation of nociceptive pain and inflammatory disorders by total steroid and terpenoid fraction of Euphorbia tirucalli Linn root in experimental in vitro and in vivo model
P Palit, D Mukherjee, P Mahanta, Shadab, N Ali, S Roychoudhury, Asad, SC Mandal
Inflammopharmacology 2017
Deciphering the mechanism behind the varied binding activities of COXIBs through Molecular Dynamic Simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies
N Chaudhary, P Aparoy
Journal of Biomolecular Structure and Dynamics 2016
Prostanoids and NSAIDs in Cardiovascular Biology and Disease
BB Weksler
Current Atherosclerosis Reports 2015
Effect of Curcumin in Experimental Peritonitis
S D, I Mani, G Ravikumar, ST Avadhany
Indian Journal of Surgery 2015
Cyclooxygenase I and II inhibitors distinctly enhance hippocampal- and cortex-dependent cognitive functions in mice
H Syed, M Ikram, A Yaqinuddin, T Ahmed
Molecular medicine reports 2015
Drug-Device Combinations For Chronic Diseases
MN Avula, DW Grainger
Drug-Device Combinations For Chronic Diseases 2015
Late Postoperative Hemorrhage in a Patient With Undiagnosed COX-1 Deficiency After Third Molar Extractions
JC Doscher, FN Volpe
Journal of Oral and Maxillofacial Surgery 2014
Effects of Danshensu on Platelet Aggregation and Thrombosis: In Vivo Arteriovenous Shunt and Venous Thrombosis Models in Rats
C Yu, D Qi, W Lian, QZ Li, HJ Li, HY Fan, PG de Frutos
PloS one 2014
First report of interruption of mast cell degranulation and endothelial cells activation by anti-inflammatory drugs controlling the acute response provoked by Pseudoplatystoma fasciatum fish venom
M Lopes-Ferreira, EM Gomes, FM Bruni, MJ Ferreira, P Charvet, C Lima
Toxicon 2014
Synthesis of Some Novel Benzoxazolinonylcarboxamides as Potential Anti-Inflammatory Agents
L Messaoud, Y Wassila, S Khemissi, A Yasmina, C Hanane
Journal of Chemical Research 2014
Evaluation of the effect of kaempferol in a murine allergic rhinitis model
HA Oh, NR Han, MJ Kim, HM Kim, HJ Jeong
European Journal of Pharmacology 2013
Enzyme Technologies: Pluripotent Players in Discovering Therapeutic Agents
T Ohshiro, H Tomoda
Enzyme Technologies: Pluripotent Players in Discovering Therapeutic Agents 2013
Anti-inflammatory and antioxidative effects of the methanolic extract of the aerial parts of M itracarpus frigidus in established animal models: Biological effects of Mitracarpus frigidus
RL Fabri, RA Garcia, JR Florêncio, NC Pinto, LG de Oliveira, JA Aguiar, A Ribeiro, E Scio
Journal of Pharmacy and Pharmacology 2013
COX inhibitors for airway inflammation
S Malhotra, SS Deshmukh, SG Dastidar
Expert Opinion on Therapeutic Targets 2012
Therapeutic Potential of Small Molecules Modulating the Cyclooxygenase-5-Lipoxygenase Pathway
W Albrecht, S Laufer
Polypharmacology in Drug Discovery Peters/Polypharmacology 2012
Description of 3 Cases in Vietnam of Aspirin Desensitization in Patients With Coronary Artery Disease and Coexisting Aspirin Hypersensitivity:
DV Nguyen, HC Chi, DV Nguyen, TJ Craig, S Nunen
World Allergy Organization Journal 2012
Clinical Use of Aspirin in Treatment and Prevention of Cardiovascular Disease
Y Dai, J Ge
Thrombosis 2012
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee
Annual Reports in Medicinal Chemistry Volume 46 2011
Influence of Experimental Subarachnoid Hemorrhage on Nicotine-induced Contraction of the Rat Basilar Artery in Relation to Arachidonic Acid Metabolites Signaling Pathway
X Ji, A Wang, CC Trandafir, K Kurahashi
Journal of Stroke and Cerebrovascular Diseases 2011
Principles of Immunopharmacology
FP Nijkamp, MJ Parnham
2011
Pharmakotherapie in der Anästhesie und Intensivmedizin
PH Tonner, L Hein
2011
Parecoxib sodium in the treatment of postoperative pain after Lichtenstein tension-free mesh inguinal hernia repair
AV Kyriakidis, I Perysinakis, I Alexandris, K Athanasiou, C Papadopoulos, I Mpesikos
Hernia 2010
Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies
W Matysiak, B Jodłowska-Jedrych
Protoplasma 2010
Cyclooxygenase-2 Expression in Animal Cancers
M Doré
Veterinary pathology 2010
Nippon Jibiinkoka Gakkai Kaiho
N Inagaki
Nippon Jibiinkoka Gakkai Kaiho 2009
Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation
E Kolaczkowska, A Goldys, E Kozakiewicz, M Lelito, B Plytycz, N Rooijen, B Arnold
Archivum Immunologiae et Therapiae Experimentalis 2009
Inhibition of iNOS and COX-2 in human whole blood ex vivo and monocyte-macrophage J774 cells by a new group of aminothiopyrimidone derivatives
V Cardile, L Lombardo, G Granata, A Perdicaro, M Balazy, A Santagati
Bioorganic & Medicinal Chemistry 2009
Nonsteroidal Anti-Inflammatory Drugs and Coxibs
TK Kvien
Rheumatoid Arthritis 2009
Kelley's Textbook of Rheumatology
J Degroot, AM Zuurmond, PP Tak
Kelley's Textbook of Rheumatology 2009
Cyclooxygenase products and atherosclerosis
MF Linton, S Fazio
Drug discovery today. Therapeutic strategies 2008
Celecoxib and ankylosing spondylitis
A Calin
Expert Review of Clinical Immunology 2008
Acute salivary gland hypofunction in the duct ligation model in the absence of inflammation
PN Correia, GH Carpenter, SM Osailan, KL Paterson, GB Proctor
Oral Diseases 2008
Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs
JG Wooten, AT Blikslager, KA Ryan, SL Marks, JM Law, BD Lascelles
American Journal of Veterinary Research 2008
In vivo and in vitro metabolism of lefucoxib in rats
X Bi, Z Meng, H Chen, X Zhu, G Dou
Journal of Pharmaceutical and Biomedical Analysis 2008
Possible role of cyclooxygenase-2 inhibitors as anticancer agents
S Boonsoda, P Wanikiat
Veterinary Record 2008
Effect of the COX-2 Inhibitor Celecoxib on Behavioural and Immune Changes in an Olfactory Bulbectomised Rat Model of Depression
AM Myint, HW Steinbusch, L Goeghegan, D Luchtman, YK Kim, BE Leonard
Neuroimmunomodulation 2007
Cyclooxygenase-1 inhibition delays recovery of the cutaneous barrier disruption caused by mechanical scratching in mice
Y Honma, I Arai, N Futaki, Y Hashimoto, M Sugimoto, T Sakurai, S Nakaike
British Journal of Dermatology 2007
Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release
ML Kowalski, M Borowiec, M Kurowski, R Pawliczak
Allergy 2007
Drug Insight: cyclo-oxygenase-2 inhibitors—a critical appraisal
B Hinz, B Renner, K Brune
Nature Clinical Practice Rheumatology 2007
Therapeutic hypothermia in acute ischemic stroke
H Hertog, B der Worp, M Gemert, D Dippel
Expert Review of Neurotherapeutics 2007
Clinical pharmacology of celecoxib, a COX-2 selective inhibitor
K Antoniou, M Malamas, AA Drosos
Expert Opinion on Pharmacotherapy 2007
Handbook of Systemic Autoimmune Diseases
M Karmegam, RJ Quigg
Handbook of Systemic Autoimmune Diseases 2007
Pharmacological nature of nicotine-induced contraction in the rat basilar artery: Involvement of arachidonic acid metabolites
X Ji, T Nishihashi, CC Trandafir, A Wang, Y Shimizu, K Kurahashi
European Journal of Pharmacology 2007
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser, S Fries, GA FitzGerald
Journal of Clinical Investigation 2006
Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism
GM Borthwick, AS Johnson, M Partington, J Burn, R Wilson, HM Arthur
The FASEB Journal 2006
Prostaglandins in Health and Disease: An Overview
SB Miller
Seminars in Arthritis and Rheumatism 2006
COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis
M Sugimoto, I Arai, N Futaki, Y Hashimoto, Y Honma, S Nakaike
Experimental Dermatology 2006
Update on COX-2 inhibitor patents with a focus on optimised formulation and therapeutic scope of drug combinations making use of COX-2 inhibitors
U Puhlmann, D Schäfer, C Ziemann
Expert Opinion on Therapeutic Patents 2006
Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on a mouse fracture model
BH Mullis, ST Copland, PS Weinhold, T Miclau, GE Lester, GD Bos
Injury 2006
Cyclooxygenase: Past, present and future. A tribute to John R. Vane (1927–2004)
RM Botting
Journal of Thermal Biology 2006
Inhibition of prostaglandins does not reduce the cardiovascular changes during endotoxemia in rats
A Azab, S Kobal, M Rubin, J Kaplanski
Prostaglandins, Leukotrienes and Essential Fatty Acids 2006
Analgesia
C Stein
Analgesia 2006
Comparative Effects of Indomethacin and Nabumetone on Urine and Electrolyte Output in Conscious Rats
I Long, HJ Singh, GJ Rao
Journal of Pharmacological Sciences 2005
Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs
JM Giraudel, A Diquelou, P Lees, PL Toutain
Journal of Veterinary Pharmacology and Therapeutics 2005
Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing
BM Peskar
InflammoPharmacology 2005
Cyclooxygenase inhibition attenuates endotoxin-induced spatial learning deficits, but not an endotoxin-induced blockade of long-term potentiation
KN Shaw, S Commins, SM O'Mara
Brain Research 2005
Neuronal prostaglandin endoperoxide synthase 2 responses to oxygen and glucose deprivation are mediated by mitogen-activated protein kinase ERK1/2
D Zhang, CE Wood
Brain Research 2005
Clinical implications of cyclo-oxygenase–2 inhibitors for acute dental pain management
M Spink, S Bahn, R Glickman
The Journal of the American Dental Association 2005
COX-2: A Molecular Target for Colorectal Cancer Prevention
JR Brown, RN DuBois
Journal of Clinical Oncology 2005
Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing
BM Peskar
Inflammopharmacology 2005
Effects of Nimesulide, a Selective Cyclooxygenase-2 Inhibitor, on Cardiovascular Alterations in Endotoxemia
AN Azab, S Kobal, M Rubin, J Kaplanski
Cardiology 2004
The discovery and development of antiinflammatory drugs
K Brune, B Hinz
Arthritis & Rheumatism 2004
The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans
W Koppert, A Wehrfritz, N Körber, R Sittl, S Albrecht, J Schüttler, M Schmelz
PAIN 2004
El ácido acetilsalicílico incrementa la expresión de CD36 en macrófagos THP-1 de forma independiente del receptor activado por proliferadores peroxisómicos gamma
M Viñals, I Bermúdez, JC Laguna
Clínica e Investigación en Arteriosclerosis 2004
Involvement of eicosanoids in the hypothermic response to lipopolysaccharide during endotoxemia in rats
AN Azab, J Kaplanski
Prostaglandins, Leukotrienes and Essential Fatty Acids 2004
Ischaemia–Reperfusion Injury in the Isolated Haemoperfused Bovine Uterus: An In Vitro Model of Acute Inflammation
M Braun, M Kietzmann
Alternatives to laboratory animals : ATLA 2004
COX-2 Inhibitors
M Pairet, J van Ryn
2004
Nabumetone: Therapeutic Use and Safety Profile in the Management of Osteoarthritis and Rheumatoid Arthritis
T Hedner, O Samulesson, P Whrborg, H Wadenvik, KA Ung, A Ekbom
Drugs 2004
Cyclooxygenase-1-Coupled Prostaglandin Biosynthesis Constitutes an Essential Prerequisite for Skin Repair
H Kämpfer, L Bräutigam, G Geisslinger, J Pfeilschifter, S Frank
Journal of Investigative Dermatology 2003
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa
S Fiorucci, L Santucci, JL Wallace, M Sardina, M Romano, P Soldato, A Morelli
Proceedings of the National Academy of Sciences 2003
Unexpected Nanomolar Inhibition of Carbonic Anhydrase by COX-2-Selective Celecoxib: New Pharmacological Opportunities Due to Related Binding Site Recognition
A Weber, A Casini, A Heine, D Kuhn, CT Supuran, A Scozzafava, G Klebe
Journal of Medicinal Chemistry 2003
Selective Cyclooxygenase-2 Inhibition: A Target in Cancer Prevention and Treatment
S Subongkot, D Frame, W Leslie, D Drajer
Pharmacotherapy 2003
The Combined Effect of Topical CX-659S, a Novel Diaminouracil Derivative, With Topical Corticosteroid on the Three Types of Allergic Responses in Mice or Guinea Pigs
Y Inoue, M Isobe, H Hayashi
Journal of Pharmacological Sciences 2003
The development of COX2 inhibitors
RJ Flower
Nature Reviews Drug Discovery 2003
Advances in Modelling and Clinical Application of Intravenous Anaesthesia
J Vuyk, S Schraag
2003
The Second Generation of COX-2 Inhibitors: What Advantages Do the Newest Offer?
DO Stichtenoth, JC Frlich
Drugs 2003
Persistence of Mucosal Mast Cells and Eosinophils in Shigella -Infected Children
R Raqib, PK Moly, P Sarker, F Qadri, NH Alam, M Mathan, J Andersson
Infection and immunity 2003
Cyclooxygenase (COX) Inhibitors: A Comparative QSAR Study
R Garg, A Kurup, SB Mekapati, C Hansch
Chemical Reviews 2003
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
ME Burleigh, VR Babaev, JA Oates, RC Harris, S Gautam, D Riendeau, LJ Marnett, JD Morrow, S Fazio, MR Linton
Circulation 2002
Osteoarthritis IV: Clinical therapeutic trials and treatment
WW Buchanan, WF Kean
InflammoPharmacology 2002
Cyclooxygenase-2 inhibitors: promise or peril?
LJ Mengle-Gaw, BD Schwartz
Mediators of Inflammation 2002
The adverse renal effects of prostaglandin-synthesis inhibition in the fetus and the newborn
A Drukker
Paediatrics & child health 2002
Design of peptides and peptidomimetics as COX-2 selective inhibitors
V Kothekar, S Sahi
Journal of Molecular Structure: THEOCHEM 2002
Cyclooxygenase-2 Expression in Cultured Cortical Thick Ascending Limb of Henle Increases in Response to Decreased Extracellular Ionic Content by Both Transcriptional and Post-transcriptional Mechanisms: ROLE OF p38-MEDIATED PATHWAYS
HF Cheng, RC Harris
The Journal of biological chemistry 2002
Prostaglandins that increase renin production in response to ACE inhibition are not derived from cyclooxygenase-1
HF Cheng, SW Wang, MZ Zhang, JA McKanna, R Breyer, RC Harris
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2002
N-3 and n-6 fatty acids stimulate restitution by independent mechanisms in the IEC-6 model of intestinal wound healing
DJ Ruthig, KA Meckling-Gill
The Journal of Nutritional Biochemistry 2002
Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human
JJ Yuan, D Yang, JY Zhang, R Bible, A Karim, JW Findlay
Drug Metabolism and Disposition 2002
Cyclooxygenase 2 and the kidney
MD Breyer, RC Harris
Current Opinion in Nephrology and Hypertension 2001
COX-2???Specific Inhibitors: Definition of a New Therapeutic Concept
KM Verburg, TJ Maziasz, E Weiner, L Loose, GS Geis, PC Isakson
American Journal of Therapeutics 2001
Drugs for the Treatment of Allergic Diseases
N Inagaki, H Nagai
The Japanese Journal of Pharmacology 2001
Guest Editorial: The Use of COX-2-Specific Inhibitors: Is It All Hype or Is It Evidence Based?
A Ince
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2001
The ‘in vivo’ and ‘ex vivo’ roles of cylcooxygenase-2, nuclear factor-κB and protein kinases pathways in the up-regulation of B1 receptor-mediated contraction of the rabbit aorta
R Medeiros, DA Cabrini, JB Calixto
Regulatory Peptides 2001
Induction of cyclooxygenase-2 in thick ascending limb cells by adrenalectomy
CP Vio, SJ An, C Céspedes, JC McGiff, NR Ferreri
Journal of the American Society of Nephrology : JASN 2001
Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury
S Cuzzocrea, RJ Reiter
European Journal of Pharmacology 2001
A perfusion technique for the determination of pro-inflammatory mediators induced by intradental application of irritants
JJ Chidiac, N Hawwa, M Baliki, B Safieh-Garabedian, K Rifai, SJ Jabbur, NE Saadé
Journal of Pharmacological and Toxicological Methods 2001
Physiological regulation of cyclooxygenase-2 in the kidney
RC Harris, MD Breyer
American journal of physiology. Renal physiology 2001
Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis
JL Goldstein, P Correa, WW Zhao, AM Burr, RC Hubbard, KM Verburg, GS Geis
The American Journal of Gastroenterology 2001
Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries
JK Hennan, J Huang, TD Barrett, EM Driscoll, DE Willens, AM Park, LJ Crofford, BR Lucchesi
Circulation 2001
Advances in Prostaglandin and Leukotriene Research
B Samuelsson, R Paoletti, GC Folco, E Granström, S Nicosia
2001
Cancer Pain: Assessment and Management
ED Bruera, RK Portenoy
2001
Regulated expression of both cyclooxygenase (COX) isoforms in a human model of inflammation: effects on generation of eicosanoids and isoeicosanoids in vivo
B.F. McAdam, I.A. Mardini, A. Habib, A. Burke, J.A. Lawson, S. Kapoor, G.A. FitzGerald
Journal of Clinical Investigation 2000
The Microcirculation and Inflammation: Site of Action for Glucocorticoids
M Perretti, A Ahluwalia
Microcirculation 2000
COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease
DA Willoughby, AR Moore, PR Colville-Nash
The Lancet 2000
Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract
J Sung, R Russell, N Yeomans, F Chan, S Chen, K Fock, K Goh, P Kullavanijaya, K Kimura, C Lau, J Louw, J Sollano, G Triadiafalopulos, S Xiao, P Brooks
Journal of Gastroenterology and Hepatology 2000
Naturally occurring antinociceptive substances from plants
JB Calixto, A Beirith, J Ferreira, AR Santos, VC Filho, RA Yunes
Phytotherapy Research 2000
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
LJ Crofford, PE Lipsky, P Brooks, SB Abramson, LS Simon, LB van de Putte
Arthritis & Rheumatism 2000
New insights into physiological and pathophysiological functions of cyclo-oxygenase-2
B Hinz, K Brune
Current Opinion in Anaesthesiology 2000
Inhibitors of cyclooxygenase-2: November 1999 - April 2000
JS Carter
Expert Opinion on Therapeutic Patents 2000
Selective cyclooxygenase-2 (COX-2) inhibitors reduce anti-Mycobacterium antibodies in adjuvant arthritic rats
À Turull, J Queralt
Immunopharmacology 2000
Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats
CJ Jones, SC Budsberg
Journal of the American Veterinary Medical Association 2000
Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs
J Steinmeyer
Arthritis research 2000
Aspirin and other anti-inflammatory drugs
SJ Vane
Thorax 2000
Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes
AV Sampey, P Hutchinson, EF Morand
Mediators of Inflammation 2000
DIAGNOSIS AND TREATMENT OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG-ASSOCIATED UPPER GASTROINTESTINAL TOXICITY
MS Cappell, JR Schein
Gastroenterology Clinics of North America 2000
The “Aspirin” of the New Millennium: Cyclooxygenase-2 Inhibitors
NS Buttar, KK Wang
Mayo Clinic Proceedings 2000
Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord
C Maihöfner, I Tegeder, C Euchenhofer, D deWitt, K Brune, R Bang, W Neuhuber, G Geisslinger
Neuroscience 2000
Spatial Requirements for 15-( R )-Hydroxy-5 Z ,8 Z ,11 Z ,13 E -eicosatetraenoic Acid Synthesis within the Cyclooxygenase Active Site of Murine COX-2: WHY ACETYLATED COX-1 DOES NOT SYNTHESIZE 15-(R)-HETE
SW Rowlinson, BC Crews, DC Goodwin, C Schneider, JK Gierse, LJ Marnett
The Journal of biological chemistry 2000
Advances in Eicosanoid Research
CN Serhan, HD Perez
2000
Cyclooxygenase-2 in the Kidney
RC Harris
Journal of the American Society of Nephrology : JASN 2000
Selective Cyclooxygenase-2 Inhibitors: Heteroaryl Modified 1,2-Diarylimidazoles Are Potent, Orally Active Antiinflammatory Agents
IK Khanna, Y Yu, RM Huff, RM Weier, X Xu, FJ Koszyk, PW Collins, JN Cogburn, PC Isakson, CM Koboldt, JL Masferrer, WE Perkins, K Seibert, AW Veenhuizen, J Yuan, DC Yang, YY Zhang
Journal of Medicinal Chemistry 2000
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2
JJ Talley, DL Brown, JS Carter, MJ Graneto, CM Koboldt, JL Masferrer, WE Perkins, RS Rogers, AF Shaffer, YY Zhang, BS Zweifel, K Seibert
Journal of Medicinal Chemistry 2000
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
JA Mitchell, TD Warner
British Journal of Pharmacology 1999
Glucocorticoids Augment Fibroblast-Mediated Contraction of Collagen Gels by Inhibition of Endogenous PGE Production
CM Sköld, XD Liu, YK Zhu, T Umino, K Takigawa, Y Ohkuni, RF Ertl, JR Spurzem, DJ Romberger, R Brattsand, SI Rennard
Proceedings of The Association of American Physicians 1999
Ex vivoassay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs
F Giuliano, TD Warner
British Journal of Pharmacology 1999
COX-2 and Alzheimer’s disease: potential roles in inflammation and neurodegeneration
MK O’Banion
Expert Opinion on Investigational Drugs 1999
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
JJ Talley, SR Bertenshaw, DL Brown, JS Carter, MJ Graneto, CM Koboldt, JL Masferrer, BH Norman, DJ Rogier, BS Zweifel, K Seibert
Medicinal Research Reviews 1999
Regulation of prostaglandin production in carrageenan-induced pleurisy melatonin
S Cuzzocrea, G Costantino, E Mazzon, AP Caputi
Journal of Pineal Research 1999
COX-1 und COX-2: Funktionen und pharmakologische Beeinflussung
B Hinz, K Brune
Pharmazie in unserer Zeit 1999
COX-2 inhibitors
CJ Hawkey
The Lancet 1999
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
XM Xu, L Sansores-Garcia, XM Chen, N Matijevic-Aleksic, M Du, KK Wu
Proceedings of the National Academy of Sciences 1999
THE USE OF ANALGESICS IN THE MANAGEMENT OF PAIN IN RHEUMATIC DISEASES
LW Moreland, EW st. Clair
Rheumatic Disease Clinics of North America 1999
SELECTIVE CYCLOOXYGENASE-2 INHIBITORS
BD Golden, SB Abramson
Rheumatic Disease Clinics of North America 1999
Management of inflammatory pain with selective COX-2 inhibitors: Promises and facts
PF Bejarano
Current Pain and Headache Reports 1999
Restricted cyclooxygenase-2 expression in the central nervous system following acute and delayed-type hypersensitivity responses to bacillus Calmette-Guérin
L Minghetti, P Hughes, VH Perry
Neuroscience 1999
Nouveaux anti-inflammatoires non stéroïdiens: donneurs de NO et inhibiteurs sélectifs de COX-2
B Bannwarth, F Berenbaum
La Revue de Médecine Interne 1999
Newer Analgesics
PM Taylor
Veterinary Clinics of North America Small Animal Practice 1999
The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat
M Yamada, M Kawai, Y Kawai, Y Mashima
Current Eye Research 1999
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
P Brooks, P Emery, JF Evans, H Fenner, CJ Hawkey, C Patrono, J Smolen, F Breedveld, R Day, M Dougados, EW Ehrich, J Gijon-Baños, TK Kvien, MH van Rijswijk, T Warner, H Zeidler
Rheumatology (Oxford, England) 1999
Non-steroidal anti-inflammatory drugs: back to the future
RJ Flower
Rheumatology (Oxford, England) 1999
Inducible Enzymes in the Inflammatory Response
DA Willoughby, A Tomlinson
1999
The action mechanism of cyclooxygenase-2 inhibitor for treatment of experimental allergic neuritis
K Miyamoto, N Oka, T Kawasaki, H Satoi, A Matsuo, I Akiguchi
Muscle & Nerve 1999
Prophylaxis and Treatment of NSAID-Induced Gastroduodenal Disorders:
RL Corte, M Caselli, G Castellino, G Bajocchi, F Trotta
Drug Safety 1999
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA
Proceedings of the National Academy of Sciences 1999
Neue nichtsteroidale Antirheumatika: Selektive Hemmstoffe der induzierbaren Cyclooxygenase
DO Stichtenoth, H Zeidler, JC Frölich
Medizinische Klinik 1998
Effects of inhibitors of the activity of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: A comparison with dexamethasone
M Leach, LC Hamilton, A Olbrich, GM Wray, C Thiemermann
British Journal of Pharmacology 1998
Effects of compounds extracted from Santolina oblongifolia on TXB2 release in human platelets
AM Silván, MJ Abad, P Bermejo, A Villar
Inflammopharmacology 1998
The potential application of cyclo-oxygenase type 2 inhibitors to Alzheimer’s disease
TA Sandson, O Felician
Expert Opinion on Investigational Drugs 1998
Recently reported inhibitors of cyclooxygenase-2
JS Carter
Expert Opinion on Therapeutic Patents 1998
Localisation of prostaglandin endoperoxide H synthase (PGHS)-1 and PGHS-2 in bone following mechanical loading in vivo
MR Forwood, WL Kelly, NF Worth
The Anatomical Record 1998
Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice
H Matsumoto, H Naraba, A Ueno, T Fujiyoshi, M Murakami, I Kudo, S Oh-ishi
European Journal of Pharmacology 1998
Mechanism of Action of Nonsteroidal Anti-inflammatory Drugs
TL Yaksh, DM Dirig, AB Malmberg
Cancer Investigation 1998
Topical glucocorticoids and the skin--mechanisms of action: an update
A Ahluwalia
Mediators of Inflammation 1998
Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes
WJ Lukiw, RP Pelaez, J Martinez, NG Bazan
Proceedings of the National Academy of Sciences 1998
The advent of highly selective inhibitors of cyclooxygenase—a review
B Cryer, A Duboisø
Prostaglandins & Other Lipid Mediators 1998
Pharmacodynamics and pharmacokinetics of tolfenamicacid in ruminating calves: Evaluation in models of acute inflammation
P Lees, QA McKellar, R Foot, G Gettinby
The Veterinary Journal 1998
Principles of Medical Biology
JO Jørgensen
Principles of Medical Biology 1998
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner
Advances in Protein Chemistry 1998
Termination of Acute-Phase Response
A Koj
General Pharmacology: The Vascular System 1998
Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1 -induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes
WJ Lukiw, RP Pelaez, J Martinez, NG Bazan
Proceedings of the National Academy of Sciences 1998
Synthesis and pharmacological evaluation of new flosulide analogues, synthesized from natural safrole
AS Lages, KC Silva, AL Miranda, CA Fraga, EJ Barreiro
Bioorganic & Medicinal Chemistry Letters 1998
Effects of lysine clonixinate on cyclooxygenase I and II in rat lung and stomach preparations
AM Franchi, GD Girolamo, AR los Santos, ML Martí, MA Gimeno
Prostaglandins, Leukotrienes and Essential Fatty Acids 1998
Selective COX-2 Inhibitors
J Vane, J Botting
1998
Mechanism of action of aspirin-like drugs
JR Vane, RM Botting
Seminars in Arthritis and Rheumatism 1997
A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes
JC Frölich
Trends in Pharmacological Sciences 1997
Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch
M PayÁ, PG PASTOR, J Coloma, MJ ALCARAZ
British Journal of Pharmacology 1997
Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases
W Neupert, R Brugger, C Euchenhofer, K Brune, G Geisslinger
British Journal of Pharmacology 1997
Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin
M Lora, S Morisset, HA Ménard, R Leduc, AJ Brum-Fernandes
Prostaglandins, Leukotrienes and Essential Fatty Acids 1997
Cyclooxygenase-2 inhibitors: A new approach to the therapy of ocular inflammation
JL Masferrer, PS Kulkarni
Survey of Ophthalmology 1997
Staphylococcal exoproducts down-regulate cyclooxygenase 1 and 2 in peritoneal macrophages
RK Mackenzie, N Topley, A Neubauer, GA Coles, JD Williams
Journal of Laboratory and Clinical Medicine 1997
Tomoxiprole Selectively Inhibits Cyclooxygenase-2
RE West, SM Williams, HS She, NI Carruthers, RW Egan, MM Billah
Prostaglandins 1997
Effect of spinal cyclooxygenase inhibitors in rat using the formalin test and in vitro prostaglandin E2 release
DM Dirig, GP Konin, PC Isakson, TL Yaksh
European Journal of Pharmacology 1997
Effects of dexamethasone administration to diestrus cows on systemic progesterone, estrogen and uterine cyclooxygenase production
JR Broussard, A Rocha, J Sirois, JD Roussel, JK Thibodeaux, RA Godke, W Hansel
Animal Reproduction Science 1997
Tumour necrosis factor-α induces cyclo-oxygenase-2 gene expression in first trimester trophoblasts: suppression by glucocorticoids and NSAIDs
HM Imseis, PD Zimmerman, P Samuels, DA Kniss
Placenta 1997
Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages
L Pang, JR Hoult
Biochemical Pharmacology 1997
Macrophage-induced nitric oxide and prostanoid dependent relaxation of arterial smooth muscles
H Wang, R Mizuno, T Ohhashi
Canadian Journal of Physiology and Pharmacology 1997
HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)
M Viñals, J Martínez-González, JJ Badimon, L Badimon
Arteriosclerosis, thrombosis, and vascular biology 1997
Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research
H Sinzinger, B Samuelsson, JR Vane, R Paoletti, P Ramwell, PY Wong
1997
Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 2
KV Honn, S Nigam, LJ Marnett
1997
Side Effects of Anti-Inflammatory Drugs IV
KD Rainsford
1997
Iontophoresis of Dexamethasone in the Treatment of Endotoxin-Induced-Uveitis in Rats
FF Behar-Cohen, JM Parel, Y Pouliquen, B Thillaye-Goldenberg, OL Goureau, S Heydolph, Y Courtois, YD Kozak
Experimental Eye Research 1997
Cyclooxygenase-1 and Cyclooxygenase-2 in the Human Optic Nerve Head
AH Neufeld, M Hernandez, M Gonzalez, A Geller
Experimental Eye Research 1997
Cyclo-Oxygenase Isoenzymes: How Recent Findings Affect Thinking About Nonsteroidal Anti-Inflammatory Drugs
JY Jouzeau, B Terlain, A Abid, E Nédélec, P Netter
Drugs 1997
Tenidap, a structurally novel drug for the treatment of arthritis: Antiinflammatory and analgesic properties
PF Moore, DL Larson, IG Otterness, A Weissman, SB Kadin, FJ Sweeney, JD Eskra, A Nagahisa, M Sakakibara, TJ Carty
Inflammation Research 1996
Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications
M Pairet, G Engelhardt
Fundamental & Clinical Pharmacology 1996
Prostaglandin synthase 2
H Herschman
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1996
Meloxican: Influence on arachidonic acid metabolism Part 1. In vitro findings
G Engelhardt
Biochemical Pharmacology 1996
Induction of cyclooxygenase and nitric oxide synthase in endotoxin-activated J774 macrophages is differentially regulated by indomethacin: Enhanced cyclooxygenase-2 protein expression but reduction of inducible nitric oxide synthase
L Pang, JR Hoult
European Journal of Pharmacology 1996
Differential inhibition of cyclooxygenase-1 (COX-1) and-2 (COX-2) by NSAIDS: Consequences on anti-inflammatory activity versus gastric and renal safety
M Pairet, L Churchill, G Trummlitz, G Engelhardt
Inflammopharmacology 1996
Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo
MR Forwood
Journal of Bone and Mineral Research 1996
Mechanism of Action of Anti-Inflammatory Drugs
JR Vane, RM Botting
Scandinavian Journal of Rheumatology 1996
Effect of Bakuchiol on Leukocyte Functions and Some Inflammatory Responses in Mice
ML Ferrándiz, B Gil, MJ Sanz, A Ubeda, S Erazo, E González, R Negrete, S Pacheco, M Payáa, MJ Alcaraz
Journal of Pharmacy and Pharmacology 1996
Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney
K Seibert, JL Masferrer, P Needleman, D Salvemini
British Journal of Pharmacology 1996
Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes
E Porreca, M Reale, CD Febbo, MD Gioacchino, RC Barbacane, ML Castellani, G Baccante, P Conti, F Cuccurullo
Immunology 1996
Interaction between nitric oxide and cyclooxygenase pathways
MD Rosa, A Ialenti, A Ianaro, L Sautebin
Prostaglandins, Leukotrienes and Essential Fatty Acids 1996
CYCLOOXYGENASE-2 INHIBITORS
JL Masferrer, PC Isakson, K Seibert
Gastroenterology Clinics of North America 1996
Advances in Lipobiology
PJ Trotter, DR Voelker
Advances in Lipobiology 1996
Meloxican: Influence on arachidonic acid metabolism
G Engelhardt, R Bögel, C Schnitzler, R Utzmann
Biochemical Pharmacology 1996
A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors
JK Gierse, JJ McDonald, SD Hauser, SH Rangwala, CM Koboldt, K Seibert
The Journal of biological chemistry 1996
Myocardial Ischemia: Mechanisms, Reperfusion, Protection
M Karmazyn
1996
Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors
J Vane, J Botting, R Botting
1996
Analgetika Antinozizeptiva Adjuvanzien
HH Waldvogel
1996
New Targets in Inflammation
N Bazan, J Botting, J Vane
1996
Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors
D Salvemini, PT Manning, BS Zweifel, K Seibert, J Connor, MG Currie, P Needleman, JL Masferrer
Journal of Clinical Investigation 1995
Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial Novel effects independent of inhibition of lipid mediator production
K Glaser
Biochemical Pharmacology 1995
Inflammation, reproduction, cancer and all that?. The regulation and role of the inducible prostaglandin synthase
HR Herschman, W Xie, S Reddy
BioEssays 1995
Eicosanoid production and levels of newly characterized eicosanoid-forming enzymes in glomeruli and tubules of rat kidneys
H YANAGISAWA, J MORRISSEY, N KURIHARA, O WADA, S KLAHR
Nephrology 1995
Cyclooxygenase selectivity and NSAIDs: Cyclooxygenase-2 selectivity of etodolac (LODINE)
KB Glaser
Inflammopharmacology 1995
Regulation of prostaglandin production by nitric oxide; an in vivo analysis
D Salvemini, SL Settle, JL Masferrer, K Seibert, MG Currie, P Needleman
British Journal of Pharmacology 1995
Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
JK Gierse, SD Hauser, DP Creely, C Koboldt, SH Rangwala, PC Isakson, K Seibert
Biochemical Journal 1995
Modulation by nitric oxide of prostaglandin biosynthesis in the rat
L Sautebin, A Ialenti, A Ianaro, MD Rosa
British Journal of Pharmacology 1995
Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression
M Goppelt-Struebe
Prostaglandins, Leukotrienes and Essential Fatty Acids 1995
Discordance between macrophage arachidonate metabolic phenotype and the expression of cytosolic phospholipase A2 and cyclooxygenase
GJ Dolecki, M Rogers, JB Lefkowith
Prostaglandins 1995
Pharmacodynamic profile of prostacyclin
JR Vane, RM Botting
The American Journal of Cardiology 1995
Signal sorting by G-protein-linked receptors
G Milligan
Advances in pharmacology (San Diego, Calif.) 1995
Diclofenac and prednisolone inhibit endotoxin-induced uveitis in rabbits
PS Kulkarni, CA Paterson
Experimental Eye Research 1995
Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774
S Milano, F Arcoleo, M Dieli, R D'Agostino, P D'Agostino, GD Nucci, E Cillari
Prostaglandins 1995
New insights into the mode of action of anti-inflammatory drugs
JR Vane, RM Botting
Inflammation Research 1995
Novel Molecular Approaches to Anti-Inflammatory Therapy
W Pruzanski, P Vadas
1995
Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids
LJ Crofford, RL Wilder, AP Ristimäki, H Sano, EF Remmers, HR Epps, T Hla
Journal of Clinical Investigation 1994
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation
D Salvemini, K Seibert, JL Masferrer, TP Misko, MG Currie, P Needleman
Journal of Clinical Investigation 1994
On Radiation Damage to Normal Tissues and its Treatment: II. Anti-inflammatory drugs
AS Michalowski
Acta Oncologica 1994
Induction of cyclooxygenase ii in human synovial microvessel endothelial cells by interleukin-1
A Szczepanski, T Moatter, WW Carley, ME Gerritsen
Arthritis & Rheumatism 1994
Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
HR Herschman, W Hall
Cancer and Metastasis Reviews 1994
Dietary protein restriction in isolated glomeruli from rats with bilateral ureteral obstruction
H Yanagisawa, N Kurihara, S Klahr, J Morrissey, O Wada
Kidney International 1994
Cytokine Regulation of Eicosanoid Generation
P Isakson, S Hauser, Y Zhang, K Leahy, J Masferrer, K Seibert
Annals of the New York Academy of Sciences 1994
Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone
JA Mitchell, MG Belvisi, P Akarasereenont, RA Robbins, OJ Kwon, J Croxtall, PJ Barnes, JR Vane
British Journal of Pharmacology 1994
Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides
G Remuzzi, M Noris, A Benigni, O Imberti, MH Sayegh, N Perico
Journal of Experimental Medicine 1994
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
JL Masferrer, BS Zweifel, PT Manning, SD Hauser, KM Leahy, WG Smith, PC Isakson, K Seibert
Proceedings of the National Academy of Sciences 1994
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
K Seibert, Y Zhang, K Leahy, S Hauser, J Masferrer, W Perkins, L Lee, P Isakson
Proceedings of the National Academy of Sciences 1994
Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats
J Waller, SM Gardiner, T Bennett
British Journal of Pharmacology 1994
The mechanism of the inhibitory effect of polyamines on the induction of nitric oxide synthase: role of aldehyde metabolites
C Szabó, GJ Southan, C Thiemermann, JR Vane
British Journal of Pharmacology 1994
Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins
P Raynal, HB Pollard
Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes 1994
Lipid Mediators
JR Vane, RM Botting
Lipid Mediators 1994
Lipocortin-derived peptides
M Perretti
Biochemical Pharmacology 1994
Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages
ST Reddy, HR Herschman
The Journal of biological chemistry 1994
Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases
G Fantuzzi, P Ghezzi
Mediators of Inflammation 1993
Nitric oxide activates cyclooxygenase enzymes
D Salvemini, TP Misko, JL Masferrer, K Seibert, MG Currie, P Needleman
Proceedings of the National Academy of Sciences 1993
Prednisolone stimulates hepatic glutathione synthesis in mice
RF Speck, C Schranz, BH Lauterburg
Journal of Hepatology 1993
Immunopharmacology of the Gastrointestinal System
L Parente, KG Mugridge
Immunopharmacology of the Gastrointestinal System 1993
Exaggerated splanchnic PGI2 release following acute hemorrhage is due to new protein synthesis
SI Myers, R Hernandez
Prostaglandins, Leukotrienes and Essential Fatty Acids 1993
Amplification of the Arachidonic Acid Cascade: Implications for Pharmacologic Intervention
NR Baird, AR Morrison
American Journal of Kidney Diseases 1993
The Molecular Basis of Eicosanoid Action
EA Meagher, GA Fitzgerald
Hypertension in Pregnancy 1993
Pathophysiology of Shock, Sepsis, and Organ Failure
G Schlag, H Redl
1993
Macrophages and Related Cells
MA Horton
1993
Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells
CC Pilbeam, H Kawaguchi, Y Hakeda, O Voznesensky, CB Alander, LG Raisz
The Journal of biological chemistry 1993
In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis
H Sano, T Hla, JA Maier, LJ Crofford, JP Case, T Maciag, RL Wilder
Journal of Clinical Investigation 1992
Methylprednisolone dosage effects on peripheral lymphocyte subpopulations and eicosanoid synthesis
S Rota, A Rambaldi, F Gaspari, M Noris, E Daina, A Benigni, A Perna, R Donadelli, G Remuzzi, S Garattini
Kidney International 1992
Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice
M Perretti, E Solito, L Parente
Agents and Actions 1992
Regulation of cyclooxygenase and thromboxane synthase in human monocytes
R NUSING, V ULLRICH
European Journal of Biochemistry 1992
Enhancement of prostaglandin E2 production by liver macrophages (Kupffer cells) after stimulation with biological response modifiers
N Kawada, Y Mizoguchi, K Kobayashi, T Monna, P Liu, S Morisawa
Prostaglandins, Leukotrienes and Essential Fatty Acids 1992
Cytokines and eicosanoids in cancer drug toxicity
P Preziosi, L Parente, P Navarra
Trends in Pharmacological Sciences 1992
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain
CD Breder, WL Smith, A Raz, J Masferrer, K Seibert, P Needleman, CB Saper
The Journal of Comparative Neurology 1992
Effects of Steroids and Immunosuppressive Drugs on Endotoxin-Uveitis in Rabbits
EO Ohia, M Mancino, PS Kulkarni
Journal of Ocular Pharmacology and Therapeutics 1992
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
JL Masferrer, K Seibert, B Zweifel, P Needleman
Proceedings of the National Academy of Sciences 1992
Human cyclooxygenase-2 cDNA
T Hla, K Neilson
Proceedings of the National Academy of Sciences 1992
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
MK O'Banion, VD Winn, DA Young
Proceedings of the National Academy of Sciences 1992
The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids
RM Palmer, L Bridge, NA Foxwell, S Moncada
British Journal of Pharmacology 1992
Glucocorticoids and prostaglandin synthesis: We cannot see the wood for the trees
D Duval, M Freyss-Beguin
Prostaglandins, Leukotrienes and Essential Fatty Acids 1992
Prostaglandin endoperoxide synthase gene structure: Identification of the transcriptional start site and 5′-flanking regulatory sequences
SA Kraemer, EA Meade, DL DeWitt
Archives of Biochemistry and Biophysics 1992
Mammalian lipoxygenases: molecular structures and functions
S Yamamoto
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1992
The Organic Chemistry of Drug Design and Drug Action
RB Silverman
The Organic Chemistry of Drug Design and Drug Action 1992
Manipulation of thromboxane synthesis by novel 26,27-dialkyl analogues of 1α,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells
A Honda, Y Mori, N Ikekawa, A Raz
European Journal of Pharmacology 1992
Protein increases glomerular eicosanoid production and activity of related enzymes
H Yanagisawa, J Morrissey, J Yates, C Hayes, S Klahr
Kidney International 1992
Possible induction of fatty acid cyclo-oxygenase in lipopolysaccharide-stimulated rat Kupffer cells
N Kawada, Y Mizoguchi, K Kobayashi, T Monna, S Morisawa, N Ueda, Y Omoto, Y Takahashi, S Yamamoto
Gastroenterology 1992
Diethylcarbamazine inhibits endothelial and microfilarial prostanoid metabolism in vitro
N Kanesa-thasan, JG Douglas, JW Kazura
Molecular and Biochemical Parasitology 1991
Endotoxin-induced arachidonic acid metabolism requires de novo protein synthesis and protein kinase C activation
J Geisel, JA Cook, KA Coffee, WC Wise, PV Halushka
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1991
Prostaglandins, Leukotrienes, Lipoxins, and PAF
JM Bailey
1991
A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein
MK O'Banion, HB Sadowski, V Winn, DA Young
The Journal of biological chemistry 1991
Cyclooxygenase gene expression is down-regulated by heparin-binding (acidic fibroblast) growth factor-1 in human endothelial cells
T Hla, T Maciag
The Journal of biological chemistry 1991
Progress in Medicinal Chemistry
JR Brown, SH Imam
Progress in Medicinal Chemistry 1985
Progress in Nucleic Acid Research and Molecular Biology
FS Collins, SM Weissman
Progress in nucleic acid research and molecular biology 1984
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs
GD Anderson, SD Hauser, KL McGarity, ME Bremer, PC Isakson, SA Gregory
Journal of Clinical Investigation 1981
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs
GD Anderson, SD Hauser, KL McGarity, ME Bremer, PC Isakson, SA Gregory
Journal of Clinical Investigation 1981
Alteration of canine renal vascular response to hemorrhage by inhibitors of prostaglandin synthesis
BF McAdam, F Catella-Lawson, IA Mardini, S Kapoor, JA Lawson, GA FitzGerald
The American journal of physiology 1976
Alteration of canine renal vascular response to hemorrhage by inhibitors of prostaglandin synthesis
BF McAdam, F Catella-Lawson, IA Mardini, S Kapoor, JA Lawson, GA FitzGerald
The American journal of physiology 1976

← Previous 1 2 3 … 11 12 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
68 readers on Mendeley
See more details